DSFIR DSM-Firmenich AG
Stock · Amsterdam · Switzerland · Basic Materials · CH1216478797
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by DSM-Firmenich AG, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR.
Updated 06 Nov 2026 17:10. Information, not advice.
Results
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 18 Feb 2027 11:00 | — | — | — | Upcoming |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 9B | -0.2% | -1.1B | -12.0% | -4.27 | -608.3% | 651M |
| 2024 | 9.1B | -14.8% | 250M | 2.8% | 0.84 | -90.8% | 1B |
| 2023 | 10.6B | +26.7% | 2.1B | 20.1% | 9.13 | -18.8% | 558M |
| 2022 | 8.4B | — | 1.7B | 20.3% | 11.24 | — | 281M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 10 Mar 2025 | 96.42 | 97.86 | 94.56 | 94.88 | -1.17% | 673,705 | |
| 07 Mar 2025 | 98.52 | 98.56 | 95.26 | 96.00 | -0.74% | 710,631 | |
| 06 Mar 2025 | 98.76 | 98.88 | 95.80 | 96.72 | -1.65% | 609,736 | |
| 05 Mar 2025 | 101.75 | 103.50 | 98.34 | 98.34 | -3.87% | 698,619 | |
| 04 Mar 2025 | 101.90 | 102.90 | 101.60 | 102.30 | +0.24% | 455,732 | |
| 03 Mar 2025 | 102.55 | 103.25 | 101.20 | 102.05 | -0.92% | 440,231 | |
| 28 Feb 2025 | 101.30 | 103.70 | 100.10 | 103.00 | +1.48% | 901,819 | |
| 27 Feb 2025 | 103.00 | 103.05 | 100.85 | 101.50 | -2.03% | 419,583 | |
| 26 Feb 2025 | 104.00 | 104.45 | 103.00 | 103.60 | -0.38% | 354,234 | |
| 25 Feb 2025 | 103.00 | 104.00 | 102.80 | 104.00 | +0.78% | 454,568 | |
| 24 Feb 2025 | 101.55 | 103.30 | 101.30 | 103.20 | +2.08% | 442,154 | |
| 21 Feb 2025 | 101.20 | 101.35 | 100.30 | 101.10 | +0.40% | 378,600 | |
| 20 Feb 2025 | 101.90 | 102.60 | 100.50 | 100.70 | -1.08% | 399,754 | |
| 19 Feb 2025 | 104.65 | 105.00 | 101.75 | 101.80 | -3.28% | 480,205 | |
| 18 Feb 2025 | 105.55 | 106.40 | 104.60 | 105.25 | -0.75% | 532,386 | |
| 17 Feb 2025 | 106.80 | 107.25 | 104.75 | 106.05 | -1.26% | 613,395 | |
| 14 Feb 2025 | 104.25 | 108.40 | 104.25 | 107.40 | +2.19% | 1,074,011 | |
| 13 Feb 2025 | 108.80 | 108.80 | 101.75 | 105.10 | +4.01% | 1,101,262 | |
| 12 Feb 2025 | 100.10 | 101.40 | 99.76 | 101.05 | +0.55% | 650,010 | |
| 11 Feb 2025 | 100.20 | 101.25 | 98.96 | 100.50 | +4.75% | 857,425 | |
| 10 Feb 2025 | 95.50 | 96.50 | 95.46 | 95.94 | +0.52% | 303,506 | |
| 07 Feb 2025 | 96.50 | 96.62 | 95.30 | 95.44 | -0.46% | 345,546 | |
| 06 Feb 2025 | 96.16 | 96.82 | 95.54 | 95.88 | -0.42% | 333,802 | |
| 05 Feb 2025 | 96.50 | 96.68 | 94.98 | 96.28 | -0.12% | 323,531 | |
| 04 Feb 2025 | 97.08 | 97.54 | 95.96 | 96.40 | -1.31% | 324,722 |
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- dsm-firmenich shares hit three-week low as Jefferies flags price pressure (opens in a new tab) Investing.com · 04 Nov 2026 07:39
- Is DSM-Firmenich (ENXTAM:DSFIR) Fully Priced Following Earnings Upgrades And Its New York Fragrance Hub? (opens in a new tab) Simply Wall St. · 15 Oct 2026 23:16
- Can DSM-Firmenich (ENXTAM:DSFIR) Stay Cheap After A 40% Rally? (opens in a new tab) Simply Wall St. · 02 Oct 2026 10:09
- DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation Upside (opens in a new tab) Simply Wall St. · 14 May 2026 14:20
- Dividend Investors: Don't Be Too Quick To Buy DSM-Firmenich AG (AMS:DSFIR) For Its Upcoming Dividend (opens in a new tab) Simply Wall St. · 07 May 2026 05:07
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 113.30 EUR
- Market cap
- 26.8B
- Dividend yield
- 2.28%
- Payout ratio
- 207%
- Last dividend
- 2.5000 EUR · 11 May 2026
- Exchange
- Amsterdam
- Country
- Switzerland
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 11 May 2026 | 2.5000 EUR |
| 08 May 2025 | 2.5000 EUR |
| 09 May 2024 | 2.5000 EUR |
| 03 Jul 2023 | 1.6000 EUR |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 9.5 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 7.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.5 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.0 / 10 | — |
| Analysts How far the analysts' average target is from today's price. | 0.0 / 5 |
|
- Score capped at 50: three or more warnings
- The dividend is above the earnings (payout 207%)
- The last full year was a loss
- Revenue has fallen two years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 26.43× | Weak | 11.51× |
| Price / book | 1.54× | Fair | 2× |
| Price / sales | 2.96× | Fair | 1.87× |
| EV / EBITDA | 22.4× | Weak | 8.74× |
| Free cash flow yield | -0.1% | Weak | 2.4% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 39.2% | Fair | 27.2% |
| Operating margin | 7.9% | Weak | 10.7% |
| Net margin | -15.2% | Weak | 4.1% |
| Return on equity | 1.9% | Weak | 7.1% |
| Return on assets | 1.2% | Weak | 4.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 2.5% | Weak | -0.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.38× | Good | 0.36× |
| Net debt / EBITDA | 3.11× | Weak | 1.32× |
| Interest cover | 3.97× | Fair | 4.02× |
| Current ratio | 1.75× | Good | 2.37× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 206.6% | Weak | 22.7% |
| Payout of free cash flow (3 years) | 88.8% | Weak | — |
| Dividend growth / year | 25% | Good | 5.6% |
| Years of rising dividends | 0 | Weak | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow DSFIR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.